Virus-Induced Risk of Hepatocellular Carcinoma: Recent Progress and Future Challenges-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Virus-Induced Risk of Hepatocellular Carcinoma: Recent Progress and Future Challenges

Published:2021-12-31 Issue:1 Volume:11 Page:208
ISSN:2077-0383
Container-title:Journal of Clinical Medicine
language:en
Short-container-title:JCM

Author:

Lupberger Joachim^ORCID,Baumert Thomas F.^ORCID

Abstract

Chronic viral hepatitis is a key risk factor for liver fibrosis and hepatocellular carcinoma (HCC) [...]

Funder

European Union

European Research Council

French Cancer Agency

National Institutes of Health

Publisher

MDPI AG

Subject

General Medicine

Link

https://www.mdpi.com/2077-0383/11/1/208/pdf

Reference18 articles.

1. Hepatocellular Carcinoma

2. Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges

3. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine

4. Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease

5. Liver damage favors the eliminations of HBV integration and clonal hepatocytes in chronic hepatitis B

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Cholangiocarcinoma (CCA) Subtype-Specific Biomarkers;2023-08-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP